APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chemical Drug and Biologic Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chemical Drug and Biologic Drug Market Analysis and Forecast 2026-2032

21 December 2025208 pages

Choose your research edition.

Industry ResearchChemical Drug and Biologic Drug Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Chemical Drug and Biologic Drug Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Chemical Drug and Biologic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chemical Drug and Biologic Drug Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Chemical Drug and Biologic Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Chemical Drug and Biologic Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Chemical Drug and Biologic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chemical Drug and Biologic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chemical Drug and Biologic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chemical Drug and Biologic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Chemical Drug and Biologic Drug include Takeda, Teva, Sanofi, Johnson & Johnson, Novartis, Novo Nordisk, Merck & Co., Roche and Eli Lilly & Co., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Chemical Drug and Biologic Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chemical Drug and Biologic Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Chemical Drug and Biologic Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chemical Drug and Biologic Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chemical Drug and Biologic Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Chemical Drug and Biologic Drug revenue, projected growth trends, production technology, application and end-user industry.

Chemical Drug and Biologic Drug Segment by Company

Takeda

Teva

Sanofi

Johnson & Johnson

Novartis

Novo Nordisk

Merck & Co.

Roche

Eli Lilly & Co.

Pfizer

GlaxoSmithKline

Biogen

Bayer

Bristol Myers Squibb

Amgen

AbbVie

AstraZeneca

Gilead Sciences

Boehringer Ingelheim

Astellas

Chemical Drug and Biologic Drug Segment by Type

Chemical Drug

Biologic Drug

Chemical Drug and Biologic Drug Segment by Application

Hospital

Retail Pharmacy

Other

Chemical Drug and Biologic Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemical Drug and Biologic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chemical Drug and Biologic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemical Drug and Biologic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Chemical Drug and Biologic Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Chemical Drug and Biologic Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chemical Drug and Biologic Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chemical Drug and Biologic Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Chemical Drug Major Player Table 3. Biologic Drug Major Player Table 4. Global Chemical Drug and Biologic Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Retail Pharmacy Major Player Table 7. Other Major Player Table 8. Chemical Drug and Biologic Drug Industry Trends Table 9. Chemical Drug and Biologic Drug Industry Drivers Table 10. Chemical Drug and Biologic Drug Industry Opportunities and Challenges Table 11. Chemical Drug and Biologic Drug Industry Restraints Table 12. Global Chemical Drug and Biologic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Chemical Drug and Biologic Drug Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Chemical Drug and Biologic Drug Market Share by Region (2021-2026) Table 15. Global Chemical Drug and Biologic Drug Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Chemical Drug and Biologic Drug Market Share by Region (2027-2032) Table 17. Global Chemical Drug and Biologic Drug Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Chemical Drug and Biologic Drug Revenue Market Share by Players (2021-2026) Table 19. Global Chemical Drug and Biologic Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Chemical Drug and Biologic Drug Key Players Headquarters & Area Served Table 21. Global Chemical Drug and Biologic Drug Players, Product Type & Application Table 22. Global Chemical Drug and Biologic Drug Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Chemical Drug and Biologic Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Chemical Drug and Biologic Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Chemical Drug and Biologic Drug Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Chemical Drug and Biologic Drug Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Chemical Drug and Biologic Drug Revenue Market Share by Type (2021-2026) Table 29. Global Chemical Drug and Biologic Drug Revenue Market Share by Type (2027-2032) Table 30. Global Chemical Drug and Biologic Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Chemical Drug and Biologic Drug Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Chemical Drug and Biologic Drug Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Chemical Drug and Biologic Drug Revenue Market Share by Application (2021-2026) Table 34. Global Chemical Drug and Biologic Drug Revenue Market Share by Application (2027-2032) Table 35. Takeda Company Information Table 36. Takeda Business Overview Table 37. Takeda Chemical Drug and Biologic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Chemical Drug and Biologic Drug Product Portfolio Table 39. Takeda Recent Development Table 40. Teva Company Information Table 41. Teva Business Overview Table 42. Teva Chemical Drug and Biologic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Teva Chemical Drug and Biologic Drug Product Portfolio Table 44. Teva Recent Development Table 45. Sanofi Company Information Table 46. Sanofi Business Overview Table 47. Sanofi Chemical Drug and Biologic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sanofi Chemical Drug and Biologic Drug Product Portfolio Table 49. Sanofi Recent Development Table 50. Johnson & Johnson Company Information Table 51. Johnson & Johnson Business Overview Table 52. Johnson & Johnson Chemical Drug and Biologic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Johnson & Johnson Chemical Drug and Biologic Drug Product Portfolio Table 54. Johnson & Johnson Recent Development Table 55. Novartis Company Information Table 56. Novartis Business Overview Table 57. Novartis Chemical Drug and Biologic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Novartis Chemical Drug and Biologic Drug Product Portfolio Table 59. Novartis Recent Development Table 60. Novo Nordisk Company Information Table 61. Novo Nordisk Business Overview Table 62. Novo Nordisk Chemical Drug and Biologic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Novo Nordisk Chemical Drug and Biologic Drug Product Portfolio Table 64. Novo Nordisk Recent Development Table 65. Merck & Co. Company Information Table 66. Merck & Co. Business Overview Table 67. Merck & Co. Chemical Drug and Biologic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Merck & Co. Chemical Drug and Biologic Drug Product Portfolio Table 69. Merck & Co. Recent Development Table 70. Roche Company Information Table 71. Roche Business Overview Table 72. Roche Chemical Drug and Biologic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Roche Chemical Drug and Biologic Drug Product Portfolio Table 74. Roche Recent Development Table 75. Eli Lilly & Co. Company Information Table 76. Eli Lilly & Co. Business Overview Table 77. Eli Lilly & Co. Chemical Drug and Biologic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Eli Lilly & Co. Chemical Drug and Biologic Drug Product Portfolio Table 79. Eli Lilly & Co. Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Chemical Drug and Biologic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Pfizer Chemical Drug and Biologic Drug Product Portfolio Table 84. Pfizer Recent Development Table 85. GlaxoSmithKline Company Information Table 86. GlaxoSmithKline Business Overview Table 87. GlaxoSmithKline Chemical Drug and Biologic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. GlaxoSmithKline Chemical Drug and Biologic Drug Product Portfolio Table 89. GlaxoSmithKline Recent Development Table 90. Biogen Company Information Table 91. Biogen Business Overview Table 92. Biogen Chemical Drug and Biologic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Biogen Chemical Drug and Biologic Drug Product Portfolio Table 94. Biogen Recent Development Table 95. Bayer Company Information Table 96. Bayer Business Overview Table 97. Bayer Chemical Drug and Biologic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Bayer Chemical Drug and Biologic Drug Product Portfolio Table 99. Bayer Recent Development Table 100. Bristol Myers Squibb Company Information Table 101. Bristol Myers Squibb Business Overview Table 102. Bristol Myers Squibb Chemical Drug and Biologic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Bristol Myers Squibb Chemical Drug and Biologic Drug Product Portfolio Table 104. Bristol Myers Squibb Recent Development Table 105. Amgen Company Information Table 106. Amgen Business Overview Table 107. Amgen Chemical Drug and Biologic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Amgen Chemical Drug and Biologic Drug Product Portfolio Table 109. Amgen Recent Development Table 110. AbbVie Company Information Table 111. AbbVie Business Overview Table 112. AbbVie Chemical Drug and Biologic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. AbbVie Chemical Drug and Biologic Drug Product Portfolio Table 114. AbbVie Recent Development Table 115. AstraZeneca Company Information Table 116. AstraZeneca Business Overview Table 117. AstraZeneca Chemical Drug and Biologic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. AstraZeneca Chemical Drug and Biologic Drug Product Portfolio Table 119. AstraZeneca Recent Development Table 120. Gilead Sciences Company Information Table 121. Gilead Sciences Business Overview Table 122. Gilead Sciences Chemical Drug and Biologic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Gilead Sciences Chemical Drug and Biologic Drug Product Portfolio Table 124. Gilead Sciences Recent Development Table 125. Boehringer Ingelheim Company Information Table 126. Boehringer Ingelheim Business Overview Table 127. Boehringer Ingelheim Chemical Drug and Biologic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Boehringer Ingelheim Chemical Drug and Biologic Drug Product Portfolio Table 129. Boehringer Ingelheim Recent Development Table 130. Astellas Company Information Table 131. Astellas Business Overview Table 132. Astellas Chemical Drug and Biologic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Astellas Chemical Drug and Biologic Drug Product Portfolio Table 134. Astellas Recent Development Table 135. North America Chemical Drug and Biologic Drug Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Chemical Drug and Biologic Drug Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Chemical Drug and Biologic Drug Revenue by Application (2021-2026) & (US$ Million) Table 138. North America Chemical Drug and Biologic Drug Revenue by Application (2027-2032) & (US$ Million) Table 139. North America Chemical Drug and Biologic Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Chemical Drug and Biologic Drug Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Chemical Drug and Biologic Drug Revenue by Country (US$ Million) & (2027-2032) Table 142. Europe Chemical Drug and Biologic Drug Revenue by Type (2021-2026) & (US$ Million) Table 143. Europe Chemical Drug and Biologic Drug Revenue by Type (2027-2032) & (US$ Million) Table 144. Europe Chemical Drug and Biologic Drug Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Chemical Drug and Biologic Drug Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Chemical Drug and Biologic Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Chemical Drug and Biologic Drug Revenue by Country (2021-2026) & (US$ Million) Table 148. Europe Chemical Drug and Biologic Drug Revenue by Country (US$ Million) & (2027-2032) Table 149. China Chemical Drug and Biologic Drug Revenue by Type (2021-2026) & (US$ Million) Table 150. China Chemical Drug and Biologic Drug Revenue by Type (2027-2032) & (US$ Million) Table 151. China Chemical Drug and Biologic Drug Revenue by Application (2021-2026) & (US$ Million) Table 152. China Chemical Drug and Biologic Drug Revenue by Application (2027-2032) & (US$ Million) Table 153. Asia Chemical Drug and Biologic Drug Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Chemical Drug and Biologic Drug Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Chemical Drug and Biologic Drug Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Chemical Drug and Biologic Drug Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Chemical Drug and Biologic Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Chemical Drug and Biologic Drug Revenue by Region (US$ Million) & (2021-2026) Table 159. Asia Chemical Drug and Biologic Drug Revenue by Region (US$ Million) & (2027-2032) Table 160. SAMEA Chemical Drug and Biologic Drug Revenue by Type (2021-2026) & (US$ Million) Table 161. SAMEA Chemical Drug and Biologic Drug Revenue by Type (2027-2032) & (US$ Million) Table 162. SAMEA Chemical Drug and Biologic Drug Revenue by Application (2021-2026) & (US$ Million) Table 163. SAMEA Chemical Drug and Biologic Drug Revenue by Application (2027-2032) & (US$ Million) Table 164. SAMEA Chemical Drug and Biologic Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Chemical Drug and Biologic Drug Revenue by Country (2021-2026) & (US$ Million) Table 166. SAMEA Chemical Drug and Biologic Drug Revenue by Country (US$ Million) & (2027-2032) Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Chemical Drug and Biologic Drug Image Figure 2. Global Chemical Drug and Biologic Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chemical Drug and Biologic Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Chemical Drug Image Figure 5. Biologic Drug Image Figure 6. Global Chemical Drug and Biologic Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Chemical Drug and Biologic Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Retail Pharmacy Image Figure 10. Other Image Figure 11. Global Chemical Drug and Biologic Drug Market Size (US$ Million) & (2021-2032) Figure 12. Global Chemical Drug and Biologic Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Chemical Drug and Biologic Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Chemical Drug and Biologic Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Chemical Drug and Biologic Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Chemical Drug and Biologic Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Chemical Drug and Biologic Drug Revenue Market Share by Type (2021-2032) Figure 19. Global Chemical Drug and Biologic Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Chemical Drug and Biologic Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Chemical Drug and Biologic Drug Revenue Market Share by Application (2021-2032) Figure 22. North America Chemical Drug and Biologic Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Chemical Drug and Biologic Drug Revenue Share by Type (2021-2032) Figure 24. North America Chemical Drug and Biologic Drug Revenue Share by Application (2021-2032) Figure 25. North America Chemical Drug and Biologic Drug Revenue Share by Country (2021-2032) Figure 26. United States Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Chemical Drug and Biologic Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Chemical Drug and Biologic Drug Revenue Share by Type (2021-2032) Figure 31. Europe Chemical Drug and Biologic Drug Revenue Share by Application (2021-2032) Figure 32. Europe Chemical Drug and Biologic Drug Revenue Share by Country (2021-2032) Figure 33. Germany Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Chemical Drug and Biologic Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Chemical Drug and Biologic Drug Revenue Share by Type (2021-2032) Figure 43. China Chemical Drug and Biologic Drug Revenue Share by Application (2021-2032) Figure 44. Asia Chemical Drug and Biologic Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Chemical Drug and Biologic Drug Revenue Share by Type (2021-2032) Figure 46. Asia Chemical Drug and Biologic Drug Revenue Share by Application (2021-2032) Figure 47. Asia Chemical Drug and Biologic Drug Revenue Share by Region (2021-2032) Figure 48. Japan Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Chemical Drug and Biologic Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Chemical Drug and Biologic Drug Revenue Share by Type (2021-2032) Figure 56. SAMEA Chemical Drug and Biologic Drug Revenue Share by Application (2021-2032) Figure 57. SAMEA Chemical Drug and Biologic Drug Revenue Share by Country (2021-2032) Figure 58. Brazil Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Chemical Drug and Biologic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Drug
  • Biologic Drug
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Takeda
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Novo Nordisk
  • Merck & Co.
  • Roche
  • Eli Lilly & Co.
  • Pfizer
  • GlaxoSmithKline
  • Biogen
  • Bayer
  • Bristol Myers Squibb
  • Amgen
  • AbbVie
  • AstraZeneca
  • Gilead Sciences
  • Boehringer Ingelheim
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chemical Drug and Biologic Drug Market by Type
  3. 1.2.1 Global Chemical Drug and Biologic Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Chemical Drug
  5. 1.2.3 Biologic Drug
  6. 1.3 Chemical Drug and Biologic Drug Market by Application
  7. 1.3.1 Global Chemical Drug and Biologic Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Retail Pharmacy
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Chemical Drug and Biologic Drug Market Dynamics
  1. 2.1 Chemical Drug and Biologic Drug Industry Trends
  2. 2.2 Chemical Drug and Biologic Drug Industry Drivers
  3. 2.3 Chemical Drug and Biologic Drug Industry Opportunities and Challenges
  4. 2.4 Chemical Drug and Biologic Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Chemical Drug and Biologic Drug Market Perspective (2021-2032)
  2. 3.2 Global Chemical Drug and Biologic Drug Growth Trends by Region
  3. 3.2.1 Global Chemical Drug and Biologic Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chemical Drug and Biologic Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Chemical Drug and Biologic Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Chemical Drug and Biologic Drug Revenue by Players
  2. 4.1.1 Global Chemical Drug and Biologic Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Chemical Drug and Biologic Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Chemical Drug and Biologic Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chemical Drug and Biologic Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Chemical Drug and Biologic Drug Key Players Headquarters & Area Served
  7. 4.4 Global Chemical Drug and Biologic Drug Players, Product Type & Application
  8. 4.5 Global Chemical Drug and Biologic Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Chemical Drug and Biologic Drug Market CR5 and HHI
  11. 4.6.3 2025 Chemical Drug and Biologic Drug Tier 1, Tier 2, and Tier 3
5 Chemical Drug and Biologic Drug Market Size by Type
  1. 5.1 Global Chemical Drug and Biologic Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Chemical Drug and Biologic Drug Revenue by Type (2021-2032)
  3. 5.3 Global Chemical Drug and Biologic Drug Revenue Market Share by Type (2021-2032)
6 Chemical Drug and Biologic Drug Market Size by Application
  1. 6.1 Global Chemical Drug and Biologic Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Chemical Drug and Biologic Drug Revenue by Application (2021-2032)
  3. 6.3 Global Chemical Drug and Biologic Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Chemical Drug and Biologic Drug Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Teva Chemical Drug and Biologic Drug Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Chemical Drug and Biologic Drug Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Johnson & Johnson
  20. 7.4.1 Johnson & Johnson Company Information
  21. 7.4.2 Johnson & Johnson Business Overview
  22. 7.4.3 Johnson & Johnson Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Johnson & Johnson Chemical Drug and Biologic Drug Product Portfolio
  24. 7.4.5 Johnson & Johnson Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Chemical Drug and Biologic Drug Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Novo Nordisk
  32. 7.6.1 Novo Nordisk Company Information
  33. 7.6.2 Novo Nordisk Business Overview
  34. 7.6.3 Novo Nordisk Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Novo Nordisk Chemical Drug and Biologic Drug Product Portfolio
  36. 7.6.5 Novo Nordisk Recent Developments
  37. 7.7 Merck & Co.
  38. 7.7.1 Merck & Co. Company Information
  39. 7.7.2 Merck & Co. Business Overview
  40. 7.7.3 Merck & Co. Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Merck & Co. Chemical Drug and Biologic Drug Product Portfolio
  42. 7.7.5 Merck & Co. Recent Developments
  43. 7.8 Roche
  44. 7.8.1 Roche Company Information
  45. 7.8.2 Roche Business Overview
  46. 7.8.3 Roche Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Roche Chemical Drug and Biologic Drug Product Portfolio
  48. 7.8.5 Roche Recent Developments
  49. 7.9 Eli Lilly & Co.
  50. 7.9.1 Eli Lilly & Co. Company Information
  51. 7.9.2 Eli Lilly & Co. Business Overview
  52. 7.9.3 Eli Lilly & Co. Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Eli Lilly & Co. Chemical Drug and Biologic Drug Product Portfolio
  54. 7.9.5 Eli Lilly & Co. Recent Developments
  55. 7.10 Pfizer
  56. 7.10.1 Pfizer Company Information
  57. 7.10.2 Pfizer Business Overview
  58. 7.10.3 Pfizer Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Pfizer Chemical Drug and Biologic Drug Product Portfolio
  60. 7.10.5 Pfizer Recent Developments
  61. 7.11 GlaxoSmithKline
  62. 7.11.1 GlaxoSmithKline Company Information
  63. 7.11.2 GlaxoSmithKline Business Overview
  64. 7.11.3 GlaxoSmithKline Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 GlaxoSmithKline Chemical Drug and Biologic Drug Product Portfolio
  66. 7.11.5 GlaxoSmithKline Recent Developments
  67. 7.12 Biogen
  68. 7.12.1 Biogen Company Information
  69. 7.12.2 Biogen Business Overview
  70. 7.12.3 Biogen Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Biogen Chemical Drug and Biologic Drug Product Portfolio
  72. 7.12.5 Biogen Recent Developments
  73. 7.13 Bayer
  74. 7.13.1 Bayer Company Information
  75. 7.13.2 Bayer Business Overview
  76. 7.13.3 Bayer Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Bayer Chemical Drug and Biologic Drug Product Portfolio
  78. 7.13.5 Bayer Recent Developments
  79. 7.14 Bristol Myers Squibb
  80. 7.14.1 Bristol Myers Squibb Company Information
  81. 7.14.2 Bristol Myers Squibb Business Overview
  82. 7.14.3 Bristol Myers Squibb Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Bristol Myers Squibb Chemical Drug and Biologic Drug Product Portfolio
  84. 7.14.5 Bristol Myers Squibb Recent Developments
  85. 7.15 Amgen
  86. 7.15.1 Amgen Company Information
  87. 7.15.2 Amgen Business Overview
  88. 7.15.3 Amgen Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Amgen Chemical Drug and Biologic Drug Product Portfolio
  90. 7.15.5 Amgen Recent Developments
  91. 7.16 AbbVie
  92. 7.16.1 AbbVie Company Information
  93. 7.16.2 AbbVie Business Overview
  94. 7.16.3 AbbVie Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  95. 7.16.4 AbbVie Chemical Drug and Biologic Drug Product Portfolio
  96. 7.16.5 AbbVie Recent Developments
  97. 7.17 AstraZeneca
  98. 7.17.1 AstraZeneca Company Information
  99. 7.17.2 AstraZeneca Business Overview
  100. 7.17.3 AstraZeneca Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  101. 7.17.4 AstraZeneca Chemical Drug and Biologic Drug Product Portfolio
  102. 7.17.5 AstraZeneca Recent Developments
  103. 7.18 Gilead Sciences
  104. 7.18.1 Gilead Sciences Company Information
  105. 7.18.2 Gilead Sciences Business Overview
  106. 7.18.3 Gilead Sciences Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Gilead Sciences Chemical Drug and Biologic Drug Product Portfolio
  108. 7.18.5 Gilead Sciences Recent Developments
  109. 7.19 Boehringer Ingelheim
  110. 7.19.1 Boehringer Ingelheim Company Information
  111. 7.19.2 Boehringer Ingelheim Business Overview
  112. 7.19.3 Boehringer Ingelheim Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Boehringer Ingelheim Chemical Drug and Biologic Drug Product Portfolio
  114. 7.19.5 Boehringer Ingelheim Recent Developments
  115. 7.20 Astellas
  116. 7.20.1 Astellas Company Information
  117. 7.20.2 Astellas Business Overview
  118. 7.20.3 Astellas Chemical Drug and Biologic Drug Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Astellas Chemical Drug and Biologic Drug Product Portfolio
  120. 7.20.5 Astellas Recent Developments
8 North America
  1. 8.1 North America Chemical Drug and Biologic Drug Revenue (2021-2032)
  2. 8.2 North America Chemical Drug and Biologic Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Chemical Drug and Biologic Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Chemical Drug and Biologic Drug Revenue by Type (2027-2032)
  5. 8.3 North America Chemical Drug and Biologic Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Chemical Drug and Biologic Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Chemical Drug and Biologic Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Chemical Drug and Biologic Drug Revenue by Application (2027-2032)
  9. 8.5 North America Chemical Drug and Biologic Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Chemical Drug and Biologic Drug Revenue by Country
  11. 8.6.1 North America Chemical Drug and Biologic Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Chemical Drug and Biologic Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Chemical Drug and Biologic Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Chemical Drug and Biologic Drug Revenue (2021-2032)
  2. 9.2 Europe Chemical Drug and Biologic Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Chemical Drug and Biologic Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Chemical Drug and Biologic Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Chemical Drug and Biologic Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Chemical Drug and Biologic Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Chemical Drug and Biologic Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Chemical Drug and Biologic Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Chemical Drug and Biologic Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Chemical Drug and Biologic Drug Revenue by Country
  11. 9.6.1 Europe Chemical Drug and Biologic Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Chemical Drug and Biologic Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Chemical Drug and Biologic Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Chemical Drug and Biologic Drug Revenue (2021-2032)
  2. 10.2 China Chemical Drug and Biologic Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Chemical Drug and Biologic Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Chemical Drug and Biologic Drug Revenue by Type (2027-2032)
  5. 10.3 China Chemical Drug and Biologic Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Chemical Drug and Biologic Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Chemical Drug and Biologic Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Chemical Drug and Biologic Drug Revenue by Application (2027-2032)
  9. 10.5 China Chemical Drug and Biologic Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chemical Drug and Biologic Drug Revenue (2021-2032)
  2. 11.2 Asia Chemical Drug and Biologic Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Chemical Drug and Biologic Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Chemical Drug and Biologic Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Chemical Drug and Biologic Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Chemical Drug and Biologic Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Chemical Drug and Biologic Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Chemical Drug and Biologic Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Chemical Drug and Biologic Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Chemical Drug and Biologic Drug Revenue by Country
  11. 11.6.1 Asia Chemical Drug and Biologic Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Chemical Drug and Biologic Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Chemical Drug and Biologic Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chemical Drug and Biologic Drug Revenue (2021-2032)
  2. 12.2 SAMEA Chemical Drug and Biologic Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Chemical Drug and Biologic Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Chemical Drug and Biologic Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Chemical Drug and Biologic Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Chemical Drug and Biologic Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Chemical Drug and Biologic Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Chemical Drug and Biologic Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Chemical Drug and Biologic Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Chemical Drug and Biologic Drug Revenue by Country
  11. 12.6.1 SAMEA Chemical Drug and Biologic Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Chemical Drug and Biologic Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Chemical Drug and Biologic Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst